The long game: Telemedicine patient satisfaction metrics and methods of recurrence detection for gynecologic cancer patients throughout the initial year of the COVID-19 pandemic

Patient perspective on virtual prechemotherapy visits in gynecologic oncology

“…This study found that most patients with gynecologic malignancy are highly satisfied with the virtual prechemotherapy visit experience and prefer a hybrid model in which telemedicine is a part of their care. These findings support previous studies demonstrating high levels of patient satisfaction with telemedicine encounters ( Wong et al, 2022 , Mojdehbakhsh et al, 2022 , Zimmerman et al, 2020 ). Given that our study was conducted after the COVID-19 pandemic, these results highlight that patient affinity for virtual care is sustained even post-pandemic.…”

“…To maximize telemedicine to its fullest potential in gynecologic oncology, understanding the patient's perspective is paramount. Previous studies have reported benefits of telemedicine including avoidance of infectious disease, reduced travel time, cost savings, and high patient and provider satisfaction ( Neeman et al, 2021 , Kraus et al, 2022 , Wong et al, 2022 , Mojdehbakhsh et al, 2022 , Zimmerman et al, 2020 ). Conversely, some studies have uncovered skepticism toward telemedicine due to limiting factors such as discomfort with technology and inability to perform physical exams ( Quam et al, 2022 , Nestlerode et al, 2022 ).…”

The development of evaluation scale of the patient satisfaction with telemedicine: a systematic review

“…Most of included studies ( n = 32) were conducted in United States [ 17 – 48 ], and a few were conducted in Italy ( n = 3) [ 49 – 51 ], Spain ( n = 2) [ 52 , 53 ], Egypt ( n = 1) [ 54 ], Australia ( n = 1) [ 55 ], India ( n = 1) [ 56 ], United Kingdom ( n = 1) [ 57 ], Canada( n = 1) [ 58 ], France ( n = 1) [ 59 ], Colombia ( n = 1) [ 60 ]. The vast majority included studies ( n = 38) reported on the types of participants’ diseases, which includes head and neck otolaryngology ( n = 1) [ 17 ], pediatric ( n = 1) [ 52 ], physical, occupational, and speech therapy ( n = 1) [ 18 ], orthopaedic ( n = 1) [ 19 ], pediatric pulmonary ( n = 1) [ 20 ], cancer ( n = 4) [ 21 , 30 , 50 , 58 ], neurology ( n = 1) [ 22 ], pediatric urology ( n = 1) [ 24 ], rhinology (n = 1) [ 25 ], neuromuscular disorder ( n = 1) [ 26 ], allergy ( n = 1) [ 27 ], pediatric diabetes ( n = 1) [ 28 ], epilepsy (n = 1) [ 56 ], prechemotherapy ( n = 1) [ 29 ], pediatric rheumatology ( n = 1) [ 32 ], neurosurgery (n = 1) [ 33 ], cystic fibrosis ( n = 1) [ 35 ], pediatric and young adult type 1 diabetes ( n = 1) [ 49 ], shoulder arthroscopy ( n = 1) [ 36 ], pediatric surgery ( n = 1) [ 53 ], vascular surgery ( n = 1) [ 57 ], maternal mental health and substance use disorder treatment ( n = 1) [ 38 ], referral ( n = 1) [ 39 ], dermatology ( n = 1) [ 40 ], endovascular neurosurgery ( n = 1) [ 41 ], gynecologic cancer ( n = 1) [ 42 ], orthopedic ( ...…”

“…While the remaining studies ( n = 6) did not limit the patient types [ 23 , 31 , 34 , 37 , 54 , 55 ]. For the evaluation questionnaire, there are part of studies ( n = 16) using existing questionnaires [ 17 , 22 , 26 , 28 , 30 , 32 – 34 , 42 , 46 , 47 , 50 , 55 , 56 , 58 , 59 ], a few of studies’ questionnaire ( n = 3) were designed based on different studies [ 21 , 24 , 49 ], several studies ( n = 7) evaluating by self-developed questionnaires [ 19 , 25 , 29 , 39 , 51 , 57 , 60 ], and some ( n = 18) studies did not mension the specific questionnaires used [ 18 , 20 , 23 , 27 , 31 , 35 – 38 , 40 , 41 , 43 – 45 , 48 , 52 – 54 ]. In addition, the questionnaires used in several studies ( n = 18) were divided into various dimensions [ 17 , 20 , 23 , 24 , 26 , 32 , 34 , 37 , 38 , 44 , 47 , 49 – 51 , 53 – 55 , 57 ].…”

Teleconsultation contribution to hospital patient satisfaction: Bibliometric analysis

“…After one year of the COVID-19 pandemic and the implementation of regular telehealth visits, patients with gynecological cancer are very satisfied with the use of telemedicine. During this period, relapse was most often diagnosed by patient-reported symptoms (Mojdehbakhsh et al 2022).…”